Fabrication and in vitro behavior of dual-function chitosan/silver nanocomposites for potential wound dressing applications

Mater Sci Eng C Mater Biol Appl. 2019 Jan 1:94:750-765. doi: 10.1016/j.msec.2018.10.012. Epub 2018 Oct 3.

Abstract

We report the synthesis and in vitro evaluation of dual-function chitosan-silver nanoparticles (CTS-AgNPs) films with potential applications as wound dressings. We attempted to formulate nanocomposite films with appropriate AgNPs concentrations to simultaneously display antibacterial activity and suitability for cell culture. Nanocomposites were obtained by CTS-mediated in situ chemical reduction of AgNO3. Circular-shape AgNPs (sizes ca. 7-50 nm) well distributed within the CTS matrices were obtained in concentrations from 0.018 to 0.573 wt%. Efficacy (bacteriostatic and bactericidal properties) of CTS-AgNPs films to decrease planktonic and biofilm bacterial growth was AgNPs concentration- and bacteria strain-dependent. Films showed significant antibacterial activity against Gram-negative E. coli and P. aeruginosa and Gram-positive S. aureus. Antibacterial activity against S. epidermidis was moderated. Films suitability for cell culture was characterized using primary human fibroblasts (HF). HF displayed cell viability higher than 90% and the characteristic fusiform morphology of adhered fibroblast upon culture on films with AgNPs concentration ≤ 0.036 wt%. HF cultured on these films also showed positive expression of tropoelastin, procollagen type I and Ki-67, characteristic proteins of extracellular matrix and proliferative cells, respectively. In vitro assays demonstrated that cytocompatibility/antibacterial properties decreased/increased as silver concentration increased, suggesting that CTS-AgNPS nanocomposite films with ≈0.04-0.20 wt% might be considered as potential temporary dual-function wound dressings.

Keywords: Antibacterial activity; Chitosan; Cytocompatibility; Silver nanoparticles; Wound dressings.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Bandages*
  • Cell Survival / drug effects
  • Chitosan / pharmacology*
  • Collagen Type I / metabolism
  • Colony Count, Microbial
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Humans
  • Ki-67 Antigen / metabolism
  • Male
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Nanocomposites / chemistry*
  • Nanocomposites / ultrastructure
  • Silver / pharmacology*
  • Spectrophotometry, Ultraviolet
  • Tropoelastin / metabolism
  • Water
  • Wounds and Injuries / therapy*

Substances

  • Anti-Bacterial Agents
  • Collagen Type I
  • Ki-67 Antigen
  • Tropoelastin
  • Water
  • Silver
  • Chitosan